Department of Pharmaceutical Analysis, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People's Republic of China.
Department of Metabolomics, Jiangsu Province Academy of Traditional Chinese Medicine and Jiangsu Branch of China Academy of Chinese Medical Sciences, Nanjing, 210028, People's Republic of China.
Eur J Drug Metab Pharmacokinet. 2021 Jan;46(1):93-104. doi: 10.1007/s13318-020-00645-1.
Ginseng is usually consumed as a dietary supplement for health care in the normal state or prescribed as a herbal medicine in pathologic conditions. Although metabolic studies of ginseng are commonly performed on healthy organisms, the metabolic characteristics in pathologic organisms remain unexplored. This study aimed to uncover the difference in intestinal metabolism of ginseng between normal and cyclophosphamide-induced immunosuppressed rats and further discuss the potential mechanisms involved.
Twelve Sprague-Dawley rats (6-8 weeks old) were randomly divided into two groups: the normal group (NG) and immunosuppressed group (ISG). Rats in the NG and ISG groups were intraperitoneally administered normal saline and cyclophosphamide injections (40 mg/kg) on the 1st, 2nd, 3rd and 10th days; on the 12th day, all rats were intragastrically administered ginseng water extract (900 mg/kg). The difference in intestinal metabolism of ginseng was compared using an ultra-high-performance liquid chromatography coupled with quadruple time-of-flight mass spectrometry-based metabolomics approach, and the diversities of gut microbiota were analyzed by 16S rRNA gene sequencing between the two groups.
The intestinal metabolomic characteristics of ginseng were significantly different between the normal and immunosuppressed rats, with the ginsenoside F (F), 20S-ginsenoside Rg (20(S)-Rg), pseudo-ginsenoside Rt (Pseudo-Rt), ginsenoside Rd (Rd), ginsenoside Rh (Rh), 20S-ginsenoside Rg (20(S)-Rg), ginsenoside compound K (CK), ginsenoside Rg (Rg) and 20S-panaxatriol (S-PPT) more abundant in immunosuppressed ones (P < 0.05). Additionally, the composition of gut microbiota was remarkably altered in the two groups, with some specific bacterial communities such as Bacteroides spp., Eubacterium spp. and Lachnospiraceae_UCG-010 spp. increased and Bifidobacterium spp. decreased in immunosuppressed rats compared with normal ones.
The intestinal metabolism of ginseng in immunosuppressed rats was significantly different from that in normal ones, which might be partly attributed to the changes in the intensity of specific gut bacteria. The outcomes of this study could provide scientific data for rationalization of ginseng use as both a dietary supplement and herbal medicine.
人参通常作为一种保健品在正常状态下被食用,或者作为一种草药在病理状态下被开处方。尽管人参的代谢研究通常在健康的生物体上进行,但在病理生物体中的代谢特征仍未被探索。本研究旨在揭示正常和环磷酰胺诱导的免疫抑制大鼠之间人参肠道代谢的差异,并进一步探讨潜在的相关机制。
12 只 Sprague-Dawley 大鼠(6-8 周龄)被随机分为两组:正常组(NG)和免疫抑制组(ISG)。NG 和 ISG 组大鼠在第 1、2、3 和 10 天分别给予生理盐水和环磷酰胺腹腔注射(40mg/kg);第 12 天,所有大鼠给予人参水提物(900mg/kg)灌胃。采用超高效液相色谱-四极杆飞行时间质谱联用代谢组学方法比较两组大鼠人参的肠道代谢差异,并通过 16S rRNA 基因测序分析两组大鼠肠道微生物群落的多样性。
正常和免疫抑制大鼠的人参肠道代谢特征存在显著差异,其中,人参皂苷 F(F)、20S-人参皂苷 Rg(20(S)-Rg)、拟人参皂苷 Rt(Pseudo-Rt)、人参皂苷 Rd(Rd)、人参皂苷 Rh(Rh)、20S-人参皂苷 Rg(20(S)-Rg)、人参皂苷 CK(CK)、人参皂苷 Rg(Rg)和 20S-人参二醇(S-PPT)在免疫抑制大鼠中更为丰富(P<0.05)。此外,两组大鼠肠道微生物群落组成发生显著改变,某些特定细菌群落如拟杆菌属、真杆菌属和lachnospiraceae_UCG-010 属增加,双歧杆菌属减少。
免疫抑制大鼠的人参肠道代谢与正常大鼠明显不同,这可能部分归因于特定肠道细菌丰度的变化。本研究的结果可为将人参作为保健品和草药使用的合理化提供科学数据。